Proactive Investors - Run By Investors For Investors

Sativa Investments signs supply deal with Swiss cannabis oil producer Alponics

The deal follows a supply agreement with a Portuguese cannabis oil firm, announced last month
Cannabis
Alponics will supply Sativa with CBD distillate and isolate

Sativa Investments PLC (LON:SATI) has agreed a commercial offtake agreement with a Swiss supplier of cannabis oil for the manufacture of cannabidiol (CBD) products in the UK.

Under the three-year deal, Switzerland firm Alponics will supply Sativa with CBD distillate and isolate until the end of 2022.  

READ: Sativa Investments inks commercial offtake agreement with Portuguese cannabis oil supplier

Alponics, which was founded by Pacific Rim Plantation Services last year and has operations in Vaud and Valais, is expected to begin production this autumn.

"This commercial agreement with Alponics further advances our smart-sourcing strategy,” said Sativa founder and chief executive, Geremy Thomas.

"We look forward to a long and mutually beneficial relationship with Alan Chaytor and his impressive team."

Last month Sativa decided to abandon a plan to grow its own cannabis produce at a 7.5-acre Wiltshire site.

The company decided sourcing raw material would provide greater returns than growing its own supply.

As part of the new strategy, Sativa announced in late May that it had signed a commercial offtake agreement with Portuguese cannabis oil supplier, MeridianTulip – Empresa Medicinal Lda.

Sativa will acquire low tetrahydrocannabinol (THC) cannabis oil for the UK manufacturer of CBD products at its Somerset headquarters.

THC is a compound in the cannabis plant that gives the “high” associated with recreational use while CBD is non-psychoactive. Medicinal cannabis, which was legalised in the UK late last year, contains CBD and low levels of THC.

View full SATI profile View Profile

Sativa Investments Timeline

Related Articles

PT exercises
December 19 2018
The Californian company is a bet on an industry that is in need of transformation
Pictured is the company's myLotus test
May 15 2019
Here we take a closer look at testing firm Concepta PLC (LON:CPT)
woman touching her skin
May 21 2019
Here we take a closer look at Integumen PLC (LON:SKIN), which has developed and digitised an artificial skin

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use